Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance"

被引：0
|
作者：
Yip, Terry Cheuk-Fung [1 ,2 ]
Chan, Henry Lik-Yuen [1 ,2 ,3 ]
Wong, Vincent Wai-Sun [1 ,2 ,3 ]
Wong, Grace Lai-Hung [1 ,2 ,3 ]
机构：
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 01期
关键词：
CARRIERS; SCORES;
D O I：
10.1016/j.jhep.2017.08.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：208 / 209
页数：3
相关论文
共 50 条
  • [1] Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Huang, Rui
    Liu, Yong
    Wang, Jian
    Xia, Juan
    Yan, Xiaomin
    Wu, Chao
    JOURNAL OF HEPATOLOGY, 2018, 68 (01) : 207 - 208
  • [2] Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance - authors' reply
    Gounder, P. P.
    Mosites, E. M.
    McMahon, B. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) : 1288 - 1289
  • [3] Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Kuang, X. -J.
    Jia, R. -R.
    Huo, R. -R.
    Yu, J. -J.
    Wang, J. -J.
    Xiang, B. -D.
    Li, L. -Q.
    Peng, Z.
    Zhong, J. -H.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (09) : 1026 - 1037
  • [4] Estimation of hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
    Park, Yewan
    Oh, Joo Hyun
    Goh, Myungji
    Sinn, Dong Hyun
    Kim, Jihye
    Gwak, Geum-Yon
    Paik, Seung Woon
    Kang, Wonseok
    Paik, Yong-Han
    Choi, Moon Seok
    Kim, Minseok Albert
    Lee, Jeonghoon
    JOURNAL OF HEPATOLOGY, 2020, 73 : S399 - S399
  • [5] Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
    Jiang, J. -F.
    Sun, J.
    Shi, J.
    Liu, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) : 1286 - 1288
  • [6] Reply to: "A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations"
    Yang, Hyun
    Bae, Si Hyun
    Jang, Jeong Won
    JOURNAL OF HEPATOLOGY, 2022, 77 (06) : 1724 - 1725
  • [7] A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Yang, Hyun
    Bae, Si Hyun
    Nam, Heechul
    Lee, Hae Lim
    Lee, Sung Won
    Yoo, Sun Hong
    Song, Myeong Jun
    Kwon, Jung Hyun
    Nam, Soon Woo
    Choi, Jong Young
    Yoon, Seung Kew
    Jang, Jeong Won
    JOURNAL OF HEPATOLOGY, 2022, 77 (03) : 632 - 641
  • [8] ANTIVIRAL THERAPY AND RISK FOR HEPATOCELLULAR CARCINOMA AFTER HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Lee, Han Ah
    Kim, Seung Up
    Kim, Beom Kyung
    Ahn, Sang Hoon
    Lee, Hyun Woong
    Kim, Ja Kyung
    Sinn, Dong Hyun
    Seo, Yeon Seok
    HEPATOLOGY, 2023, 78 : S449 - S450
  • [9] A RISK PREDICTION MODEL FOR HEPATOCELLULAR CARCINOMA AFTER HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Yang, Hyun
    Jang, Jeong Won
    Bae, Si Hyun
    Nam, Heechul
    Lee, Hae Lim
    Lee, Sung Won
    Yoo, Sun Hong
    Song, Myeong Jun
    Kwon, Jung Hyun
    Lee, Ahlim
    Nam, Soon Woo
    Choi, Jong Young
    Yoon, Seung Kew
    HEPATOLOGY, 2022, 76 : S238 - S238
  • [10] Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma
    Song, Ci
    Zhu, Jian
    Ge, Zijun
    Yu, Chengxiao
    Tian, Ting
    Wang, Hui
    Han, Jing
    Shen, Hongbing
    Dai, Juncheng
    Lu, Jianquan
    Hu, Zhibin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1204 - 1206
12345